Masutani R, Ikemoto T, Maki A, Tanada H, Iwatani Y, Watanabe M, Takubo T, Okada Y. Mean platelet component and mean platelet volume as useful screening markers for myelodysplastic syndrome.
Health Sci Rep 2018;
1:e50. [PMID:
30623074 PMCID:
PMC6266360 DOI:
10.1002/hsr2.50]
[Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2017] [Revised: 03/19/2018] [Accepted: 04/06/2018] [Indexed: 01/01/2023] Open
Abstract
BACKGROUND
Hematologic disorders, including myelodysplastic syndrome (MDS), are difficult to identify in routine hematologic examinations using automated hematology analyzers. However, the practical uses of mean platelet component and mean platelet volume (MPV) measured by these analyzers as screening markers for MDS, remain unclear.
METHODS
Mean platelet component and MPV values were measured in the peripheral blood of patients with MDS, aplastic anemia, idiopathic thrombocytopenic purpura, myeloproliferative neoplasms, and in healthy controls using an automated hematologic analyzer. Cutoff values for discriminating between the MDS group and healthy controls were determined by recursive partitioning analysis.
RESULTS
Mean platelet component was significantly lower in MDS patients compared with controls, while MPV was significantly higher. Combined cutoff values for MDS diagnosis of <25.3 g/dL for mean platelet component and >10.0 fL for MPV showed a specificity and positive predictive value of 99.9% and 99.1%, respectively. These cutoff values also differentiated between MDS and diagnoses of aplastic anemia, idiopathic thrombocytopenic purpura, and myeloproliferative neoplasms.
CONCLUSION
Mean platelet component and MPV may, thus, be useful and convenient screening markers for MDS.
Collapse